Neurocrine Biosciences, Inc. (NBIX) Reports In-Line Q1 Loss of 1c

May 2, 2012 4:56 PM EDT Send to a Friend
Get Alerts NBIX Hot Sheet
Trade NBIX Now!
Join SI Premium – FREE
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q1 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the quarter came in at $11.3 million versus the consensus estimate of $10.84 million.

For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment